FOCIS-iSBTc Satellite Symposium
Cellular Immunology and the Immunotherapy of Cancer V

Thursday, May 15, 2003
Paris, France

Michael T. Lotze, MD
University of Pittsburgh, Pittsburgh, PA

Michael B. Atkins, MD
Beth Israel Deaconess Medical Center, Boston, MA

Laurence Zitvogel, MD, PhD
Institute Gustave Roussy, Cedex, France

13:00-13:05	Welcome and Introduction Michael T. Lotze, MD Michael B. Atkins, MD Laurence Zitvogel, MD, PhD
13:05-13:45	Keynote Address: The Extended IL-12 Family Members: IL-12, IL-23, and IL-27 Giorgio Trinchieri, MD - Schering-Plough Research Institute, Dardilly, France
14:00-14:30	Directed Delivery of IL-1 Family Members at the Immunological Synapse Anna Rubartelli, MD - National Cancer Research Institute, Genova, Italy
14:30-15:00	Application of IL-1 Family Members in Cancer Therapy Michael T. Lotze, MD - University of Pittsburgh, Pittsburgh, PA
15:00-15:30	Exosome Clinical Trials Laurence Zitvogel, MD, PhD - Institute Gustave Roussy, Cedex, France
15:30-16:00	Measuring Immunity in Melanoma Clinical Trials Ulrich Keilholz, MD - UKBF, Free University, Berlin, Germany
16:00-16:30	Circulating Tumor Cells in Peripheral Blood as Surrogate Efficacy Marker for Cancer Immunotherapies Hans Loibner, PhD - Igeneon AG, Vienna, Austria
16:30-17:00	Tumor Vaccines: Which Adjuvant? Vincent Brichard, MD, PhD - GlaxoSmithKline Biologicals, Rixensart, Belgium
17:00-17:30	Tetramer Analysis of Class I and Class II Reactive T-Cells Markus J. Maeurer, MD - University of Mainz, Mainz, Germany
17:30-18:00	Application of IL-2 and other Cytokines in Renal Cancer Michael B. Atkins, MD - Beth Israel Deaconess Medical Center, Boston, MA